Hester Biosciences Share Price

2,485.20-13.66 (-0.55%)

NSE

Live
As On: 05 Sep, 2024, 01:17 PM IST
As On: 05 Sep, 2024, 01:17 PM IST

Sector: Agriculture/Hor...
Industry: Livestock - Pharma

STOCK SCORE

Unlock Scores

Add to Watchlist

Open2,534.00
High2,535.70
Low2,465.05
Prev Close2,498.85
Volume4,187
VWAP(₹)2,495.29

Hester Biosc share price insights

Employee & Interest Expense
Company has spent 6.49% of its operating revenues towards interest expenses and 21.06% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 5.23% as compared to Nifty Smallcap 100 which gave a return of 84.96%. (as of last trading session)
Hester Biosc Share Price Update
Hester Biosciences Ltd. share price moved down by -0.55% from its previous close of Rs 2,498.85. Hester Biosciences Ltd. stock last traded price is 2,485.20
Share Price Value
Today/Current/Last 2,485.202,483.55
Previous Day 2,498.852,500.55

Share Price	Value
Today/Current/Last	2,485.202,483.55
Previous Day	2,498.852,500.55

Hester Biosc Share Price Returns

1 Day	-0.55%
1 Month	-10.66%
3 Months	44.38%
1 Year	40.12%
3 Years	4.66%
5 Years	53.96%

Key Metrics

PE Ratio(x)	109.00
EPS - TTM(₹)	22.75
MCap(₹ Cr.)	2,112.17
MCap Rank	7
PB Ratio(x)	7.02
Div Yield(%)	0.24
Face Value(₹)	10.00
52W High(₹)	3,379.00
52W Low(₹)	1,292.85
MCap/Sales	3.88
Beta(1 Month)	0.44
BV/Share(₹)	356.04

Hester Biosc Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Hester Biosc News & Analysis

View all Hester Biosc Share News & Announcements

Hester Biosc Financials

Consolidated

Income (P&L)

	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Income	83.49	83.40	67.97	74.81	89.00
Total Income Growth (%)	0.11	22.70	-9.14	-15.94	26.26
Total Expenses	68.75	67.08	60.58	61.52	78.89
Total Expenses Growth (%)	2.50	10.73	-1.54	-22.01	29.35
EBIT	14.74	16.33	7.40	13.29	10.11
EBIT Growth (%)	-9.70	120.73	-44.34	31.46	6.43
Profit after Tax (PAT)	6.34	4.95	3.98	4.09	5.87
PAT Growth (%)	28.00	24.25	-2.50	-30.38	29.53
EBIT Margin (%)	17.66	19.57	10.88	17.76	11.36
Net Profit Margin (%)	7.59	5.94	5.86	5.46	6.59
Basic EPS (₹)	8.80	7.52	4.73	4.75	7.89

	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Income	74.52	74.08	66.49	67.65	81.20
Total Income Growth (%)	0.60	11.42	-1.73	-16.69	31.73
Total Expenses	62.09	62.54	56.51	57.02	71.53
Total Expenses Growth (%)	-0.72	10.68	-0.90	-20.29	36.51
EBIT	12.43	11.54	9.98	10.64	9.68
EBIT Growth (%)	7.77	15.59	-6.17	9.91	4.63
Profit after Tax (PAT)	8.43	7.43	6.48	6.78	6.47
PAT Growth (%)	13.47	14.76	-4.53	4.81	3.32
EBIT Margin (%)	16.68	15.57	15.01	15.72	11.92
Net Profit Margin (%)	11.31	10.03	9.74	10.02	7.97
Basic EPS (₹)	9.91	8.74	7.61	7.97	7.61

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	315.18	281.24	248.75	219.02	189.64
Total Revenue Growth (%)	12.07	13.06	13.57	15.49	2.35
Total Expenses	287.84	245.50	195.67	165.59	148.31
Total Expenses Growth (%)	17.25	25.47	18.16	11.65	15.49
Profit after Tax (PAT)	18.89	26.63	39.48	34.43	29.17
PAT Growth (%)	-29.06	-32.56	14.68	18.03	-29.82
Operating Profit Margin (%)	15.47	16.93	24.31	28.00	26.57
Net Profit Margin (%)	6.20	10.00	16.80	16.06	15.91
Basic EPS (₹)	24.88	32.96	46.41	40.79	36.44

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	289.42	259.32	224.01	210.13	172.35
Total Revenue Growth (%)	11.60	15.77	6.61	21.92	-1.11
Total Expenses	252.69	215.40	170.75	150.06	131.12
Total Expenses Growth (%)	17.31	26.15	13.79	14.45	14.49
Profit after Tax (PAT)	27.16	32.34	39.52	39.90	31.22
PAT Growth (%)	-16.03	-18.16	-0.96	27.79	-28.80
Operating Profit Margin (%)	14.66	19.85	25.40	30.70	27.30
Net Profit Margin (%)	9.52	12.73	18.01	19.13	18.42
Basic EPS (₹)	31.93	38.02	46.45	46.90	36.70

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 6.49% of its operating revenues towards interest expenses and 21.06% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Balance Sheet

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	662.35	669.97	562.16	411.05	386.60
Total Assets Growth (%)	-1.14	19.18	36.76	6.32	29.10
Total Liabilities	359.47	381.42	294.77	175.09	180.11
Total Liabilities Growth (%)	-5.75	29.40	68.35	-2.79	52.25
Total Equity	302.88	288.55	267.39	235.96	206.49
Total Equity Growth (%)	4.97	7.91	13.32	14.27	13.99
Current Ratio (x)	2.03	1.53	2.01	2.63	1.91
Total Debt to Equity (x)	0.82	0.96	0.86	0.38	0.54
Contingent Liabilities	143.57	145.74	170.20	2.05	1.52

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	549.55	545.82	424.44	282.02	277.19
Total Assets Growth (%)	0.68	28.60	50.50	1.74	15.38
Total Liabilities	236.83	253.43	156.01	44.43	74.11
Total Liabilities Growth (%)	-6.55	62.44	251.14	-40.05	21.89
Total Equity	312.71	292.38	268.43	237.58	203.08
Total Equity Growth (%)	6.95	8.92	12.99	16.99	13.17
Current Ratio (x)	2.09	1.58	2.22	4.03	2.12
Total Debt to Equity (x)	0.43	0.56	0.45	0.02	0.19
Contingent Liabilities	260.34	260.76	276.50	104.93	107.06

All figures in Rs Cr, unless mentioned otherwise

Cash Flows

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	48.13	23.60	8.81	58.05	36.77
Net Cash used in Investing Activities	-22.65	-77.00	-116.59	-38.37	-74.47
Net Cash flow from Financing Activities	-26.05	41.76	111.61	-18.22	18.74
Net Cash Flow	-0.41	-11.59	3.48	-2.26	-17.12
Closing Cash & Cash Equivalent	12.75	13.16	24.75	21.27	23.53
Closing Cash & Cash Equivalent Growth (%)	-3.10	-46.84	16.37	-9.61	-42.11
Total Debt/ CFO (x)	4.97	11.36	25.27	1.48	2.96

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	42.81	33.36	15.91	40.07	25.82
Net Cash used in Investing Activities	-20.63	-71.96	-110.58	-2.69	-21.33
Net Cash flow from Financing Activities	-24.07	41.38	94.96	-41.33	-1.39
Net Cash Flow	-1.89	2.77	0.28	-3.95	3.10
Closing Cash & Cash Equivalent	2.41	4.30	1.53	1.24	5.19
Closing Cash & Cash Equivalent Growth (%)	-44.01	181.48	22.83	-76.03	148.13
Total Debt/ CFO (x)	3.12	4.93	7.67	0.11	1.52

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 22.65 cr for investing activities which is an YoY decrease of 70.58%. (Source: Consolidated Financials)

Ratios

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	6.47	9.51	15.18	15.08	14.50
Return on Capital Employed (%)	8.46	8.64	12.28	17.16	16.06
Return on Assets (%)	2.85	3.97	7.02	8.37	7.54
Interest Coverage Ratio (x)	3.25	7.06	18.14	9.09	6.61
Asset Turnover Ratio (x)	0.46	0.43	0.53	52.14	47.40
Price to Earnings (x)	62.89	48.78	58.82	47.39	27.03
Price to Book (x)	4.05	4.62	8.88	7.14	3.91
EV/EBITDA (x)	22.03	23.66	34.11	23.22	14.21
EBITDA Margin (%)	21.11	24.71	31.37	34.21	33.70

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	8.68	11.06	14.72	16.79	15.37
Return on Capital Employed (%)	9.25	12.31	15.93	25.87	21.12
Return on Assets (%)	4.94	5.92	9.31	14.14	11.26
Interest Coverage Ratio (x)	10.13	9.27	26.43	16.22	9.19
Asset Turnover Ratio (x)	0.52	0.52	0.62	73.92	61.12
Price to Earnings (x)	43.67	40.00	58.48	40.98	25.25
Price to Book (x)	3.78	4.42	8.61	6.86	3.88
EV/EBITDA (x)	25.39	24.11	37.25	22.18	14.75
EBITDA Margin (%)	18.09	23.70	29.73	35.32	32.84

Peer Comparison

Ratio Performance
NAME P/E (x) P/B (x) ROE % ROCE % ROA % Rev CAGR [3Yr] OPM NPM Basic EPS Current Ratio Total Debt/ Equity (x) Total Debt/ CFO (x)
Hester Biosc 109.14 6.98 6.47 8.46 2.85 12.76 15.47 5.43 24.88 2.03 0.82 4.97
Annual Ratios (%)
Stock Performance
- TABLE
NAME 1D 1W 1M 3M 1Y 3Y 5Y
Hester Biosc Stock Performance -0.88 3.00 -18.86 49.04 42.06 4.31 53.69
All values in %

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Hester Biosc	109.14	6.98	6.47	8.46	2.85	12.76	15.47	5.43	24.88	2.03	0.82	4.97

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Hester Biosc Stock Performance	-0.88	3.00	-18.86	49.04	42.06	4.31	53.69

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 5.23% as compared to Nifty Smallcap 100 which gave a return of 84.96%. (as of last trading session)

Mutual Funds Ownership

MF Ownership as on 31 July 2024

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.02
  Amount Invested (in Cr.)
- 0.1%
  % of AUM
- -7.41
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
Board Meeting
Quarterly Results
Jul 25, 2024
Final
60%
May 10, 2024
Board Meeting
Audited Results & Dividend
May 02, 2024

Board Meetings

Announced on	Meeting on
Jul 25, 2024	Aug 02, 2024
Quarterly Results
May 02, 2024	May 10, 2024
Audited Results & Dividend
Jan 24, 2024	Feb 02, 2024
Quarterly Results
Oct 27, 2023	Nov 07, 2023
Quarterly Results
Jul 31, 2023	Aug 08, 2023
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 10, 2024 Aug 22, 2024 60%
May 17, 2023 Sep 13, 2023 80%
May 20, 2022 Aug 11, 2022 100%
Jun 08, 2021 Aug 05, 2021 100%
Jun 26, 2020 Aug 27, 2020 66%
Bonus
Announced on Ex-Date
Aug 14, 2012 Sep 27, 2012
Bonus Ratio: 1 share(s) for every 2 shares held
Splits
No Data Available
Rights
Announced on Ex-Date
Nov 15, 2005 May 29, 2006
Rights ratio: 2 share for every 5 held at a price of Rs 70.0

Announced on	Ex-Date	Dividend%
May 10, 2024	Aug 22, 2024	60%
May 17, 2023	Sep 13, 2023	80%
May 20, 2022	Aug 11, 2022	100%
Jun 08, 2021	Aug 05, 2021	100%
Jun 26, 2020	Aug 27, 2020	66%

Announced on	Ex-Date
Aug 14, 2012	Sep 27, 2012
Bonus Ratio: 1 share(s) for every 2 shares held

Announced on	Ex-Date
Nov 15, 2005	May 29, 2006
Rights ratio: 2 share for every 5 held at a price of Rs 70.0

AGM/EGM Meetings

Announced on	Meeting on
Aug 23, 2023	Sep 20, 2023
Rs.8.0000 per share(80%)Final Dividend & A.G.M.
Mar 28, 2023	May 02, 2023
-
Jul 23, 2021	Aug 17, 2021
Book closure from Aug 7, 2021 to Aug 17, 2021
Jul 23, 2021	-
Book closure from Aug 7, 2021 to Aug 17, 2021
Jul 23, 2021	-
Book closure from Aug 7, 2021 to Aug 17, 2021

About

Hester Biosciences Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 2,125.74 Crore) operating in Agriculture/Horticulture/Livestock sector.

Hester Biosciences Ltd. key Products/Revenue Segments include Poultry & Poultry Farming, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.

For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 83.49 Crore, up .11 % from last quarter Total Income of Rs 83.40 Crore and down 6.19 % from last year same quarter Total Income of Rs 89.00 Crore. Company has reported net profit after tax of Rs 6.63 Crore in latest quarter.

The company’s top management includes Dr.Bhupendra Gandhi, Mr.Rajiv Gandhi, Ms.Priya Gandhi, Mr.Ameet Desai, Mr.Anil Jain, Mr.Ashok Bhadakal, Mr.Jatin Trivedi, Ms.Sandhya Patel, Mr.Ravin Gandhi, Mr.Sanjiv Gandhi, Ms.Nina Gandhi, Mr.Nikhil Jhanwar, Mr.Vinod Mali. Company has Chandulal M Shah & Co. as its auditors. As on 30-06-2024, the company has a total of .85 Crore shares outstanding.

About Hester Biosc

Hester Biosciences Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 2,125.74 Crore) operating in Agriculture/Horticulture/Livestock sector. Hester Biosciences Ltd. key Products/Revenue Segments include Poultry & Poultry Farming, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 83.49 Crore, up .11 % from last quarter Total Income of Rs 83.40 Crore and down 6.19 % from last year same quarter Total Income of Rs 89.00 Crore. Company has reported net profit after tax of Rs 6.63 Crore in latest quarter.The company’s top management includes Dr.Bhupendra Gandhi, Mr.Rajiv Gandhi, Ms.Priya Gandhi, Mr.Ameet Desai, Mr.Anil Jain, Mr.Ashok Bhadakal, Mr.Jatin Trivedi, Ms.Sandhya Patel, Mr.Ravin Gandhi, Mr.Sanjiv Gandhi, Ms.Nina Gandhi, Mr.Nikhil Jhanwar, Mr.Vinod Mali. Company has Chandulal M Shah & Co. as its auditors. As on 30-06-2024, the company has a total of .85 Crore shares outstanding.

Industry

Livestock - Pharma

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap

Address

�Pushpak� 1st Floor,Panchvati Circle,Motilal Hirabhai Road,Ahmedabad, Gujarat - 380006

Contact

mail@hester.in

http://www.hester.in

Executive Leadership

Bhupendra Gandhi

Chairman

Rajiv Gandhi

Managing Director & CEO

Priya Gandhi

Executive Director

Ameet Desai

Independent Director

Auditors

Chandulal M Shah & Co.

Shah Karia & Associates

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

1 Day	-0.67%
1 Month	-10.7%
3 Months	44.2%
1 Year	40.02%
3 Years	4.53%
5 Years	53.09%

PE Ratio(x)	109.15
EPS - TTM(₹)	22.75
MCap(₹ Cr.)	2,108.30
MCap Rank	7
PB Ratio(x)	7.00
Div Yield(%)	0.24
Face Value(₹)	10.00
52W High(₹)	3,375.45
52W Low(₹)	1,292.90
MCap/Sales	3.88
Beta(1 Month)	0.40
BV/Share(₹)	356.04

Hester Biosciences Share Price

Hester Biosc share price insights

Hester Biosc Share Price Returns

Key Metrics

Hester Biosc Share Recommendations

Hester Biosc News & Analysis

Hester Biosc Financials

Income (P&L)

Balance Sheet

Cash Flows

Ratios

Peer Comparison

Ratio Performance

Stock Performance

Mutual Funds Ownership

Motilal Oswal BSE Healthcare ETF-G

Equity: Sectoral-Pharma

Corporate Actions

Recent

Board Meetings

Dividends

Bonus

Splits

Rights

AGM/EGM Meetings

About

About Hester Biosc

Executive Leadership

Auditors

Equity Quick Links

More from Markets

Trending in Markets

Most Recent

Most Read

Browse Companies

Trending Now

Popular Categories

Hot on Web

In Case you missed it

More from our network

Latest News

Download ET APP

Follow us on

become a member